CD8A and Miyoshi myopathy: Furthermore, Rosenblatt et al. (20), using dendritic cell/MM cell fusion vaccine following autologous stem cell transplantation, showed that vaccination resulted in expansion of MM-specific CD8+ T cells, and cytoreduction of minimal residual disease.